Most recent by Stephen Y. Chui, MD
SPONSORED CONTENT
February 25, 2011
2 min read
Save
Evolving insight into personalized therapy requires changes in health care delivery, reimbursement
Editor’s Note: Dr. Chui’s editorial is in response to an article in the Feb. 10 edition, “Iniparib may approve benefits of gemcitabine-carboplatin in triple-negative breast cancer.”